HNSCC
Clinical trials for HNSCC explained in plain language.
Never miss a new study
Get alerted when new HNSCC trials appear
Sign up with your email to follow new studies for HNSCC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy for head and neck cancer shows promise but study halted early
Disease control TerminatedThis study tested whether adding danvatirsen to the standard immunotherapy pembrolizumab could help people with advanced head and neck cancer that has come back or spread. About 69 adults with incurable disease were planned to join, with two-thirds getting the combination and one…
Matched conditions: HNSCC
Phase: PHASE2 • Sponsor: Flamingo Therapeutics NV • Aim: Disease control
Last updated May 26, 2026 08:41 UTC
-
Cancer drug trial cut short after enrolling only 7 patients
Disease control TerminatedThis study tested whether the drug abemaciclib could shrink tumors in people with HPV-negative head and neck cancer before they had surgery. Only 7 patients took part, and the trial was stopped early. The goal was to see if the drug could help control the disease, not cure it.
Matched conditions: HNSCC
Phase: PHASE2 • Sponsor: University of Arizona • Aim: Disease control
Last updated May 22, 2026 13:52 UTC